Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Cosenza – page 2

23 clinical trials in Cosenza, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Cosenza at a glance
23
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

23 trials in Cosenza

Open in trial search

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Asparaginase
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Chronic kidney disease

Not yet recruiting

Phase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Chronic kidney disease

Not yet recruiting

Study on Finerenone for Slowing Chronic Kidney Disease Progression in Patients Receiving Standard Care

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:The George Institute For Global Health
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Ospedale San Raffaele S.r.l.

IgA nephropathy

Not yet recruiting

Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Fondazione Schena Centro Europeo Della Ricerca Sulle Malattie Renali

A study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Plasma cell myeloma

Not recruiting

Study on Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Transplant

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Universita' Degli Studi Di Torino

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Embolism venous+1

Not recruiting

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Comparison of nilotinib versus imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Cosenza

What the registry says about research in the country

01 Hematologic Malignancies

Groundbreaking research focusing on multiple myeloma treatments, including novel combinations of therapies for newly diagnosed patients. Studies evaluating carfilzomib with different drug combinations and maintenance strategies.

  • Multiple Myeloma Treatment Protocols
  • Post-Transplant Maintenance Therapies
  • Novel Drug Combinations

Advanced clinical trials investigating treatment outcomes and long-term disease management.

02 Leukemia Research

Innovative studies targeting various forms of leukemia, including chronic lymphocytic leukemia and chronic myeloid leukemia. Research focuses on targeted therapies and treatment optimization.

  • BCR-ABL+ Treatment Strategies
  • Combination Therapies
  • Young Patient Protocols

Emphasis on developing personalized treatment approaches for different patient populations.

03 Rare Cancers

Comprehensive research on rhabdomyosarcoma in both children and adults, exploring various treatment phases and therapeutic combinations.

  • Frontline Chemotherapy Protocols
  • Radiotherapy Optimization
  • Maintenance Strategies

Integration of novel therapeutic approaches for improved patient outcomes.

04 Chronic Conditions

Innovative research addressing chronic kidney disease, investigating various therapeutic agents to slow disease progression and improve patient outcomes.

  • Disease Progression Management
  • Standard Care Enhancement
  • Treatment Optimization

Focus on developing effective interventions for long-term disease management.

05 Thrombosis Studies

Advanced research on venous thromboembolism in cancer patients, comparing various anticoagulation strategies and treatment approaches.

  • Cancer-Associated VTE
  • Comparative Treatment Studies
  • Bleeding Risk Management

Evaluation of novel therapeutic agents for improved patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.